Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...

Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...

Humana reported a $480 million profit and higher-than-expected growth of its Medicare Advantage business that has been hit with higher costs.

As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...

The company said third-quarter earnings per share were $4.16 on revenue of $29.4 billion. Analysts anticipated earnings per ...

Securities updated its ratings on several healthcare stocks, according to thefly.com, indicating a mixed outlook for the ...

Humana has faced a series of shocks this year, including surprise jumps in expenses and a deterioration in crucial Medicare ...

The insurer said it doesn’t expect earnings growth next year due to significant investments it plans to make to boost MA ...

As previously reported, BofA upgraded Humana (HUM) to Neutral from Underperform with a price target of $308, up from $247, on the results of ...

Shares of Humana Inc. HUM rose 1.98% to $260.60 Tuesday, on what proved to be an all-around favorable trading session for the ...

UnitedHealth Group Inc. shares rose as much as 9.3% before U.S. markets opened, while shares of Humana Inc. gained as much as ...

Humana’s earnings beat Wall Street expectations, but the insurer said 2025 results might come in lower than analysts project, ...